119 related articles for article (PubMed ID: 36103773)
21. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
[TBL] [Abstract][Full Text] [Related]
22. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
[TBL] [Abstract][Full Text] [Related]
23. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual.
Shang S; Chen K; Cai G; Bai X; Chen X; Li Q
Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710
[TBL] [Abstract][Full Text] [Related]
24. Generation of induced pluripotent stem cell line (VRISGi004-A) from a healthy female donor by reprogramming erythroid progenitor cells.
Luong TH; Pham TA; Nhung Nguyen TH; Nguyen XH
Stem Cell Res; 2024 Apr; 76():103331. PubMed ID: 38341988
[TBL] [Abstract][Full Text] [Related]
25. Establishment of human iPSC line NCCSi003-A from CD34
Fernandes S; Tembe S; Shinde P; Melinkeri S; Kale V; Limaye L
Stem Cell Res; 2018 Mar; 27():1-4. PubMed ID: 29274886
[TBL] [Abstract][Full Text] [Related]
26. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
[TBL] [Abstract][Full Text] [Related]
27. Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75year old female.
Martins S; Bohndorf M; Schröter F; Assar F; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2018 Jan; 26():76-79. PubMed ID: 29268155
[TBL] [Abstract][Full Text] [Related]
28. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
[TBL] [Abstract][Full Text] [Related]
29. Generation of induced pluripotent stem cell line (ZZUi0026-A) from a patient with spinocerebellar ataxia type 3.
Fang J; Wang Y; Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Xu Y; Zhang X; Kan Q
Stem Cell Res; 2021 May; 53():102205. PubMed ID: 34087977
[TBL] [Abstract][Full Text] [Related]
30. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
[TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
[TBL] [Abstract][Full Text] [Related]
32. Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects.
Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
Stem Cell Res; 2019 May; 37():101448. PubMed ID: 31077962
[TBL] [Abstract][Full Text] [Related]
33. Generation of iPSC line MU011.A-hiPS from homozygous α-thalassemia fetal skin fibroblasts.
Tangprasittipap A; Satirapod C; Jittorntrum B; Lertritanan S; Anurathaphan U; Phanthong P; Borwornpinyo S; Kitiyanant N; Hongeng S
Stem Cell Res; 2015 Nov; 15(3):506-9. PubMed ID: 26432158
[TBL] [Abstract][Full Text] [Related]
34. Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation.
Murakami N; Ishikawa T; Kondo T; Imamura K; Tsukita K; Enami T; Funayama M; Shibukawa R; Matsumoto S; Izumi Y; Ohta E; Obata F; Kaji R; Inoue H
Stem Cell Res; 2017 Oct; 24():36-39. PubMed ID: 29034893
[TBL] [Abstract][Full Text] [Related]
35. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
36. Lymphoblast-derived integration-free iPSC line AD-TREM2-3 from a 74 year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
Martins S; Yigit H; Bohndorf M; Graffmann N; Fiszl AR; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2018 Jul; 30():141-144. PubMed ID: 29902745
[TBL] [Abstract][Full Text] [Related]
37. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
[TBL] [Abstract][Full Text] [Related]
38. Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts.
Hansen M; Varga E; Wüst T; Brouwer N; Beauchemin H; Mellink C; van der Kevie-Kersemaekers AM; Möröy T; van der Reijden B; von Lindern M; van den Akker E
Stem Cell Res; 2017 Jan; 18():26-28. PubMed ID: 28395797
[TBL] [Abstract][Full Text] [Related]
39. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
40. Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():1-5. PubMed ID: 29246570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
